Core of demand generation:
When patients ask, and doctors push, launches accelerate.
You cleared the FDA. You built the sales team. You’re six months post-launch, and case volumes are still flat. We’ve seen it before. Companies take two to three years to bring a device to market, but lack a solid marketing foundation when they’re ready to hit the launch button.
The sales rep model works — up to a point
Relationships in medicine are real, and a rep who knows the clinical landscape and has earned a physician’s trust can open doors that no campaign can. That part of the model is sound. The gap is everything else.
Providers see so many patients. Many don’t know which ones are candidates for your technology. The patients themselves have no idea the option exists. So your rep shows up, makes a great impression, leaves materials, and then … waits. The patient who should have been referred last Tuesday went home with the old approach. And you have something better.
Top 5 best practices for high-performance lead generation
The competitors pulling ahead aren’t just running better rep training. They’re building demand before the rep ever walks in the door, and patients are a big part of how they do it.
When a patient already understands their condition, knows the options, and comes in asking for a specific treatment by name, the clinical encounter shifts. The provider isn’t introducing the technology. They’re responding to someone who arrived informed and motivated. That’s a different conversation entirely.
The mechanics look like this:
Disease-state content
Distribute through condition-specific search, social media, and patient community channels.
Targeted by geography
Go after markets where you already have provider capacity.
Short videos
Explain how the condition affects a person’s daily life and how a newer approach can make a difference.
Paid search campaigns
Build campaigns around symptom queries, not product names.
Patient advocacy partnerships
Place your education materials in the hands of people who are already looking for answers.
Ready to go-to-market with a new strategy?
Submit this form to schedule a consultation, or contact Don Poe directly at 303-449-6086.
A company using this go-to-market model and reported more than 75% case volume increases in target geographies.
They didn’t add headcount.
They changed what patients were asking for when they showed up at their doctor’s office.
When to talk to providers
Provider demand generation takes a different approach. A physician or surgeon isn’t searching for solutions on their phone at midnight. They’re making decisions inside a system — influenced by peers, constrained by what the hospital will buy, and skeptical of anything that smells like a vendor pitch.
What actually moves providers is peer credibility. A colleague they respect presenting outcomes data at a webinar carries more weight than a rep visit. The practical version of this is a CME-accredited, clinical webinar built around real cases and run by physicians who use your device, not by your marketing team. It gives a busy clinician a reason to show up and a reason to stay. Format matters – a 45-minute product demo disguised as an “educational” session will be ignored or resented. Genuine peer-to-peer case discussion, with the product as context rather than subject, earns trust.
Email campaigns
Email campaigns targeted at physicians may work, but only if they’re segmented and sequenced by where the physician is in their awareness of the technology. A cardiologist who attended your webinar six weeks ago needs different content than one who’s never heard of you. The first is ready for case studies and clinical data. The second needs to understand the problem the device solves before they’ll care about how it solves it. Many medtech email programs send the same message to both and wonder why engagement is low.
Social connections
LinkedIn is a great way to connect in the medtech industry. Surgeons and interventionalists are on it, and they can be reached by specialty, institution type, and geography. Short-form video of KOLs discussing clinical rationale, not polished brand content, but something that feels like a colleague talking through a case, performs well. A 30-second clip from a longer interview with an early adopter, posted consistently and targeted to the right specialties, reaches people who would never click a banner ad.
Account-based strategy
Account-based approaches work for high-value targets: IDN health systems, major academic medical centers, large surgical groups. These accounts have long buying cycles involving clinical champions, value analysis committees, procurement, and sometimes the CFO. Getting in front of the physician is a start, and they’re going to need your help to become the clinical champion you need. That clinical champion often believes in your device but can’t close internal procurement on their own. Equipping them with health economics materials such as cost-per-procedure analysis, DRG impact, and reimbursement documentation has been shown to significantly shorten deal timelines.
Conferences
Attending conferences goes without saying, but passive booth presence isn’t demand generation. The companies doing it well are running pre-conference ABM campaigns to book meetings before the event, then using those conversations to qualify accounts and enter them into post-conference nurture sequences. The conference is the handshake. The communication afterward is where demand gets built.
One analysis found deals closed 55% faster when marketing provided economic content the physician could hand off internally.
Putting both together
The most effective commercialization strategies use both. Traditional rep-driven outreach in markets where you already have clinical believers. Patient education programs built around the actual disease states your device addresses. Not brochures, but engaging content that helps patients understand their options and know what to ask for.
Your digital presence matters too. Most healthcare decisions start with some form of research long before anyone calls a rep. If a patient or clinician searches for information about your technology and finds nothing useful, you’ve already lost them.
Your sales team needs different tools matched to how different buyers actually decide. Physicians want clinical evidence without having to decode it. Administrators want to see the operational and cost case. Procurement has an entirely different checklist. One message doesn’t get you all three.
Generic messaging is a problem
Walk through any medical device company’s materials, and you’ll find lines like “innovative solutions for better outcomes” or “designed to restore quality of life.” Not wrong. Just invisible. Generic. Every competitor is saying some version of the same thing.
What moves people is personal impact. A patient deciding whether to pursue a procedure isn’t making a rational calculation; they’re imagining what Tuesday morning will look like six months from now, or going for a run, meeting friends, seeing their children.
A surgeon evaluating a new tool is thinking about how it fits the cases they do on Thursdays, not about the clinical study abstract.
If your message doesn’t speak to something real and specific, the data doesn’t matter. Your audiences have to feel it before they can process it.
What’s next?
We help medtech companies build the content, tools, and strategies that connect the clinical story to commercial results — patient education, sales enablement, omnichannel campaigns, and the strategic messaging that ties it all together.
Together, let’s start to plan now and set you up for success with your next launch.
Ready to go-to-market with a new strategy?
Submit this form to schedule a consultation, or contact Don Poe directly at 303-449-6086.
